News

News Highlights

  • December 28, 2021 — Thrive Bioscience announces it will be exhibiting at the “Society for Laboratory Automation and Screening (SLAS) 2022 International Conference & Exhibition” in Boston, February 5 to 9, 2022.
  • December 27, 2021 — United States Patent and Trademark Office (USPTO) allows two patent applications by Thrive Bioscience, “Method and System for Cell Operations using a Blockchain Data Network” and “Method and System for Cell Operations Using the Internet of Things.” Thrive Bioscience’s intellectual property portfolio now includes 78 patent applications in the U.S., China, Europe, and Japan, of which 27 have been issued or allowed.
  • December 20, 2021 — Thrive Bioscience announces it will be presenting at two life science industry conferences: the “Biotech Showcase: The Investor Conference for Innovators” and at “Digital RESI at JPM,” both in January 2022.
  • December 9, 2021 — Thomas Forest Farb-Horch, CEO of Thrive Bioscience, speaks at “IVYFON (Ivy Family Office Network) New York City Family Office Outlook 2022 Forum,” in person and simulcast on the topic, “Good Science Needs Good Cells!”
    https://ivyfon.com/
  • October 18, 2021 — Thrive Bioscience announces new capabilities of the CellAssist with the addition of carbon dioxide gas control (retrofittable), 20x magnification objective (in addition to its 4x and 10x), imaging of 386-well plates, and new video capture capabilities.
  • September 7, 2021 — Karen Stein joins as Executive Vice President to lead commercialization efforts at Thrive Bioscience. Karen has 35 years of experience as a growth strategy consultant and in sales and marketing executive roles at ALPCO Diagnostics, Thermo Fisher Scientific, Brooks Automation, and Millipore.
  • July 30, 2021 — United States Patent and Trademark Office (USPTO) issues patent application, “Cell Culture Incubators with Integrated Imaging Systems” to Thrive Bioscience. The Company’s intellectual property portfolio now includes 71 patent applications in the U.S., China, Europe, and Japan, of which 21 have been issued or allowed.
  • June 14, 2021 — Thrive Bioscience releases a new video providing a comprehensive overview of the CellAssist, a state-of-the-art automated imaging system that provides high-resolution stitched images with excellent registration. The unique capabilities and applications outlined in the video enable researchers to gain deeper insights into cell dynamics and greatly improve the reproducibility of cell culture experiments. Watch the full CellAssist demo video at:
    https://ww.thrivebio.com/the-cellassist
  • May 12, 2021 — Thrive Bioscience releases a new video to cover a recently conducted interview with Steven Sheridan, Ph.D., Senior Research Investigator, Center for Genomic Medicine, Massachusetts General Hospital. During the “Researcher’s Insight” interview, Dr. Sheridan provided an in-depth overview of how the CellAssist addresses his laboratory’s cell culture pain points. Watch the full interview at:
    https://ww.thrivebio.com/the-cellassist
  • April 26, 2021 — Thrive Bioscience announces the promotion of Michael Moody, M.S., from the position of Director, Software Development to Vice President, Software Engineering.
  • April 1, 2021 — Thrive Bioscience announces major new imaging capabilities within the industry for tissue culture and suspension cell culture now available to customers starting with Version 1.9 of the CellAssist software releases. Version 1.9 Introduces important new “3D” cell line imaging functionality with its user-customizable selection of five to 60 focal planes and distances of five to 50 µm between focal planes.
  • March 19, 2021 — Thrive Bioscience wins first place in “Innovator’s Pitch Challenge” among 30 leading life science companies at industry-leading conference, “Digital RESI (Redefining Early Stage Investments),” produced by Boston-based Life Science Nation, LLC in March 2021.
    https://www.lifesciencenation.com/
  • March 19, 2021 — Thomas Farb-Horch serves as a panelist on “Investing in Newest Tools to Advance Research at Digital RESI (Redefining Early Stage Investments),” with four leading venture and corporate venture capitalists.
  • March 19, 2021 — Thrive Bioscience wins second place in “Innovator’s Pitch Challenge” at industry-leading conference, “4D (Devices, Diagnostics, Drugs, and Digital Health) Meets Artificial Intelligence (AI),” produced by Boston-based Life Science Nation, LLC in March 2021.
  • February 25, 2021 — Thrive Bioscience promotes Ira Schaefer, J.D., from the position of Vice President, Intellectual Property to General Counsel. Mr. Schaefer has overseen the growth of Thrive’s important IP portfolio upon joining Thrive from Hogan Lovells.
  • February 18, 2021 — Thrive Bioscience enters into a distribution agreement for the CellAssist with AS ONE CORPORATION, headquartered in Osaka, Japan. AS ONE is a leading supplier of research instruments in Japan.
  • January 7, 2021 — Thrive Bioscience enters into a distribution agreement with J.C. Gonzalez, Inc., a leading provider for laboratory equipment and consumables in San Germán, Puerto Rico for distribution of the CellAssist family products in Puerto Rico.
  • January 2, 2021 — Thrive Bioscience enters into a distribution agreement with D-Mark Biosciences, a premier provider for laboratory equipment and consumables in Scarborough, Ontario to market the CellAssist family products in Canada.
  • October 1, 2020 — Thrive Bioscience announces filing of four patent applications for improving cell culture utilizing technologies in the fields of the Internet of Things (IoT), blockchain, image processing and automatic focusing.

 

  • September 1, 2020 — Thrive Bioscience presents at the AI, Big Data, and Digital Health Conference on September 8, 2020.

 

  • June 8, 2020 – Thrive Bioscience presents at the MedInvest Infectious Disease and Immunology Conference on June 15, 2020.

 

  • May 15, 2020 — Thrive Bioscience named one of “50 Fastest Growing Companies of 2020” by Silicon Review.

 

  • March 30, 2020 — Herb Kenny, former Vice President of Global Sales, Scientific Instruments at Thermo Fisher Scientific, joins Thrive Bioscience as Chief Commercial Officer, completing the senior management team for commercializing Thrive Bioscience’s family of products to significantly improve cell culture.

 

  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.
  • December 31, 2019 — Thrive Bioscience in December completes first five sales of its CellAssist instrument with shipments to commercial customers in Japan, Korea and the U.S.

 

  • November 1, 2019 — Thrive Bioscience files U.S. patent applications on blockchain and the internet of things (IOT) to cell culture. Thrive’s patent portfolio now consists of over 50 applications related to cell culture of which eight have issued.

 

  • August 9, 2019 — Thrive Bioscience named one of 20 Most Promising Biotech Solution Providers 2019 and one of 20 Best Biotech Companies of 2019 by CIO (Chief Information Officer) Review.

 

  • June 5, 2019 — Jeff Goldman, former R&D Manager at Agilent Technologies, joins Thrive Bioscience as Vice President of Engineering & Manufacturing to oversee the productization and manufacturing of Thrive’s family of cell culture instruments.

 

  • January 1, 2019 — Ira J. Schaefer, Esq., former Partner at Hogan Lovells, joins Thrive Bioscience as Vice President of Intellectual Property to oversee and continue the expansion of Thrive Bioscience’s intellectual property portfolio.
  • September 17, 2018 — Takashi Kiyoizumi, M.D., Ph.D., M.B.A, joins Thrive Bioscience as Executive Vice President of International and Senior Advisor to CEO.

 

  • April 5, 2018 — Thrive Bioscience licenses-in on an exclusive basis from an internationally-recognized research institute, an imaging-related portfolio of eight patent applications of which six have issued. Thrive Bioscience’s patent portfolio now includes 34 patent applications of which seven have issued.
  • July 7, 2016 — Thrive Bioscience announces instruments and services agreement with the Harvard Stem Cell Institute.